Not dramatic weight loss, but a subtle shift in how the midsection feels and looks, particularly in the lower abdomen where visceral fat tends to concentrate
The pill form of the medication works the same way as the injectable GLP-1s
Patients should stop the medication and contact their healthcare provider immediately if they experience: Severe or persistent abdominal pain (especially if radiating to the back), which could indicate pancreatitis Persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Yellowing of skin or eyes (jaundice) or pale stools Unexplained fever Severe diarrhoea lasting more than 48 hours Treatment continuation is reviewed regularly, with decisions based on efficacy, tolerability, and ongoing clinical need
By days 67, as nausea fades, gradually return to normal meals
Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke